Product
Berinert
2 clinical trials
3 indications
Indication
End-Stage Renal DiseaseIndication
Chronic Kidney DiseaseIndication
AngioedemaClinical trial
A Phase I/II, Double-Blind, Placebo-Controlled Study: Assessing Safety and Efficacy of Preoperative Renal Allograft Infusions of C1 Inhibitor (Berinert®) (Human) (C1INH) vs. Placebo Administration in Recipients of a Renal Allograft From Deceased High Risk Donors and Its Impact on Delayed Graft Function (DGF) and Ischemia/Reperfusion Injury (IRI)Status: Active (not recruiting), Estimated PCD: 2022-07-31
Clinical trial
Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced AngioedemaStatus: Completed, Estimated PCD: 2018-10-05